Overview
Multi-center, prospective non-interventional study to collect data on the early use of ADSTILADRIN in the US. Data will be collected from participants, caregivers and prescribing physicians in a real-world setting.
Eligibility
Inclusion Criteria:
- Prescribed and scheduled treatment with ADSTILADRIN per physician discretion or received the first instillation of ADSTILADRIN per physician discretion after 5 September 2023 but prior to site activation
- Signed and dated ICF.
- Age 18 years or older at day ICF is signed.
Exclusion Criteria:
- Currently enrolled in a clinical trial.
- Participants who have previously been treated with ADSTILADRIN in the context of a clinical trial
- Participant is pregnant or breastfeeding.